Mishiya Matsumoto Selected Research

Mishiya Matsumoto Research Topics

Disease

8	Ischemia 12/2009 - 02/2002
6	Spinal Cord Injuries (Spinal Cord Injury) 03/2024 - 12/2004
5	Spinal Cord Ischemia 10/2015 - 10/2004
3	Hypertension (High Blood Pressure) 01/2018 - 01/2006
3	Brain Ischemia (Cerebral Ischemia) 08/2012 - 02/2002
3	Tachycardia (Tachyarrhythmias) 06/2009 - 01/2006
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 01/2018
2	Pain (Aches) 06/2009 - 10/2007
2	Infarction (Infarctions) 07/2004 - 02/2002
1	Asthma (Bronchial Asthma) 09/2020
1	Respiratory Sounds (Crackle) 09/2020
1	Intracranial Embolism 05/2020
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2018
1	Diabetes Mellitus 01/2018
1	Double Outlet Right Ventricle 01/2017
1	Hemorrhage 01/2017
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2017
1	Hypoplastic Left Heart Syndrome 01/2017
1	Septic Shock (Toxic Shock Syndrome) 01/2015
1	Myotonic Dystrophy (Dystrophia Myotonica) 12/2014
1	Postoperative Cognitive Complications 11/2014
1	Drug Resistant Epilepsy 05/2014
1	Wounds and Injuries (Trauma) 04/2010
1	Fat Embolism 04/2010
1	Edema (Dropsy) 04/2010
1	Infections 06/2009
1	Hematoma 06/2009
1	Hyperthermia 05/2009
1	Unconsciousness (Loss of Consciousness) 05/2009
1	Neuroleptic Malignant Syndrome 05/2009
1	Tremor (Tremors) 05/2009
1	Cerebral Infarction 03/2009
1	Alkalosis 01/2008
1	Ascites 01/2008
1	Pseudomyxoma Peritonei 01/2008
1	Rare Diseases (Rare Disease) 01/2008
1	Huntington Disease (Huntington's Disease) 11/2007
1	Hyperglycemia 11/2007
1	Stroke (Strokes) 03/2007

Drug/Important Bio-Agent (IBA)

4	Isoflurane FDA LinkGeneric 01/2018 - 01/2009
4	Anesthetics (Anesthetic Agents)IBA 05/2009 - 10/2004
3	Oxygen (Dioxygen)IBA 12/2009 - 01/2007
3	Fentanyl (Sublimaze)FDA LinkGeneric 06/2009 - 01/2006
2	Nitrous Oxide (Laughing Gas)IBA 01/2018 - 01/2018
2	Erythropoietin FDA Link 10/2015 - 03/2007
2	Proteins (Proteins, Gene)FDA Link 12/2009 - 01/2007
2	Insulin (Novolin)FDA Link 11/2007 - 06/2006
2	Adenosine (Adenocard)FDA LinkGeneric 07/2004 - 02/2002
2	1,3-dipropyl-8-cyclopentylxanthineIBA 07/2004 - 02/2002
2	Adenosine A1 ReceptorIBA 07/2004 - 02/2002
1	SolutionsIBA 03/2024
1	Ringer's SolutionIBA 03/2024
1	HydrogenIBA 03/2024
1	Sevoflurane (Ultane)FDA LinkGeneric 09/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 10/2015
1	Insulin-Like PeptidesIBA 10/2015
1	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 05/2014
1	Glutamic Acid (Glutamate)FDA Link 05/2014
1	TrioleinIBA 04/2010
1	Aquaporin 4IBA 04/2010
1	Aquaporins (Water Channels)IBA 04/2010
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 12/2009
1	p38 Mitogen-Activated Protein KinasesIBA 12/2009
1	CosmeticsIBA 06/2009
1	Dantrolene (Dantrium)FDA LinkGeneric 05/2009
1	Vecuronium Bromide (Vecuronium)FDA LinkGeneric 05/2009
1	Secretory Proteinase Inhibitory ProteinsIBA 03/2009
1	Caspase 3 (Caspase-3)IBA 03/2009
1	Leukocyte Elastase (Neutrophil Elastase)IBA 03/2009
1	sivelestatIBA 03/2009
1	Morphine (MS Contin)FDA LinkGeneric 01/2009
1	Remifentanil (Ultiva)FDA Link 01/2009
1	Opioid Analgesics (Opioids)IBA 01/2009
1	Calcium Chloride (Calcium Chloride, Anhydrous)FDA LinkGeneric 01/2008
1	Potassium Chloride FDA LinkGeneric 01/2008
1	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 01/2008
1	ElectrolytesIBA 01/2008
1	Expectorants (Mucolytics)IBA 01/2008
1	antineoplaston A10 (A 10)IBA 11/2007
1	Blood Glucose (Blood Sugar)IBA 11/2007

Therapy/Procedure

6	Anesthesia 09/2020 - 01/2006
1	General Anesthesia 09/2020
1	Cholecystectomy 09/2020
1	Thrombectomy 05/2020
1	Transcatheter Aortic Valve Replacement 05/2020
1	Fontan Procedure (Fontan Operation) 01/2017
1	Craniotomy 01/2017
1	Hemoperfusion 01/2015
1	Cesarean Section (Caesarean Section) 12/2014
1	Vascular Surgical Procedures 11/2014
1	Neuroanesthesia 08/2012
1	Orthopedic Procedures 04/2010
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 06/2009
1	Tourniquets 06/2009
1	Operative Surgical Procedures 01/2008
1	Gastrostomy 11/2007
1	Glycemic Control 11/2007
1	Epidural Analgesia 10/2007
1	Intravenous Administration 03/2007